MONTY TEW, MD
Rheumatology Physician · WEST LAKE HILLS, TX
Individual Active NPI 1942266689
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 681 | 120,231 | $3,208,456 | $1,479,167 | $1,163,626 |
| 2023 | 680 | 147,177 | $3,660,948 | $1,671,080 | $1,323,329 |
| 2022 | 706 | 154,214 | $5,634,986 | $2,133,877 | $1,686,368 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 56,201 | $5 | $4 |
| J3262 | Injection, tocilizumab, 1 mg | 31,632 | $6 | $5 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 14,100 | $11 | $9 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,975 | $42 | $33 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,440 | $30 | $24 |
| J0897 | Injection, denosumab, 1 mg | 1,140 | $25 | $20 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 887 | $16 | $12 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 723 | $122 | $87 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 374 | $87 | $65 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 233 | $60 | $48 |
| 96372 | Injection of drug or substance under skin or into muscle | 185 | $14 | $11 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 116 | $67 | $53 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Rheumatology Physician | 207RR0500X | ✓ | K3023 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Rheumatology Physician providers in Texas
- NPI 1710168661
- NPI 1609059211
- NPI 1912961384
- NPI 1679291009
- NPI 1285609503
- NPI 1942356563
- NPI 1003058934
- NPI 1912294976
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.